Max Financial Q1 FY27 Results (NSE: MFSL)
Signal: Earnings grew
The read
Q1FY27 marked an operating recovery after the Q4FY26 consolidated loss of ₹32 crore: revenue grew 16.8% YoY to ₹14,969.51 crore, EBIT grew 43.2% to ₹173.45 crore and owner PAT grew 37.2% to ₹95.56 crore, but the trajectory remains highly dependent on Axis Max Life and carries regulatory uncertainty from the SEBI show-cause notice.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹14,969.51 Cr | 16.8% | 38.6% |
| EBIT | ₹173.45 Cr | 43.2% | |
| Net profit | ₹95.56 Cr | 37.2% | |
| EPS | ₹2.78 | 36.9% | |
| EBIT margin | 0 |
P&L walk
Consolidated revenue rose to ₹14,969.51 crore, +16.8% YoY and +38.6% QoQ, while EBIT increased 43.2% YoY to ₹173.45 crore as the life-insurance segment result rose 40.3% YoY to ₹168.24 crore; PAT attributable to owners increased 37.2% YoY to ₹95.56 crore.
Segments
Life Insurance drove the group recovery, with segment result rising 40.3% YoY to ₹168.24 crore from ₹119.95 crore, while Business Investments remained loss-making at ₹1.89 crore and unallocated costs widened to ₹28.43 crore from ₹16.43 crore.
Key positives
- Consolidated revenue increased 16.8% YoY to ₹14,969.51 crore after declining 12.7% YoY in Q4FY26.
- EBITDA grew 42.8% YoY to ₹173.95 crore and EBIT grew 43.2% YoY to ₹173.45 crore, materially ahead of revenue growth.
- Life Insurance segment result increased 40.3% YoY to ₹168.24 crore, the primary driver of the consolidated recovery.
- EPS rose 36.9% YoY to ₹2.78, broadly tracking 37.2% growth in owner-attributable PAT.
Key concerns
- Finance costs increased 80.5% YoY to ₹35.53 crore, substantially faster than revenue growth.
- The parent company's standalone revenue was only ₹3.05 crore, +2.0% YoY, versus consolidated revenue of ₹14,969.51 crore, leaving earnings concentrated in the subsidiary.
- Premium income of ₹7,275.42 crore, +18.2% YoY, was accompanied by policyholders' expenses of ₹14,788.09 crore, +16.6% YoY, highlighting the low-margin nature of reported insurance revenue.
Research and educational content only. Not investment advice.